Ghost Tree Capital, LLC Mirati Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $3.89 Million - $6.35 Million	-140,000 Reduced 70.0%	60,000 $2.61 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $2.17 Million - $2.97 Million	60,000 Added 42.86%	200,000 $7.23 Million
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $2.19 Million - $3.26 Million	-60,000 Reduced 30.0%	140,000 $5.21 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.03 Million - $2.47 Million	25,000 Added 14.29%	200,000 $9.06 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $3.87 Million - $5.64 Million	65,000 Added 59.09%	175,000 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $3.52 Million - $7.98 Million	90,000 Added 450.0%	110,000 $7.38 Million
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $758,199 - $1.51 Million	-10,000 Reduced 33.33%	20,000 $1.64 Million
Q4 2021 Feb 16, 2022	SELL	$132.01 - $190.29 $3.96 Million - $5.71 Million	-30,000 Reduced 50.0%	30,000 $4.4 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $1.32 Million - $1.77 Million	10,000 Added 20.0%	60,000 $10.6 Million
Q4 2020 Feb 18, 2021	SELL	$162.05 - $240.27 $8.1 Million - $12 Million	-50,000 Reduced 50.0%	50,000 $11 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $6.48 Million - $9.61 Million	40,000 Added 66.67%	100,000 $22 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $10.8 Million - $15.9 Million	-95,000 Reduced 61.29%	60,000 $9.96 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $2.88 Million - $4.82 Million	40,000 Added 34.78%	155,000 $17.7 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $2.44 Million - $4.07 Million	-35,000 Reduced 23.33%	115,000 $8.84 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $8.85 Million - $16.1 Million	-125,000 Reduced 45.45%	150,000 $19.3 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $4.67 Million - $6.58 Million	-60,000 Reduced 17.91%	275,000 $21.4 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $11 Million - $19.4 Million	185,000 Added 123.33%	335,000 $34.5 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $10.9 Million - $19.7 Million	-250,000 Reduced 62.5%	150,000 $11 Million
Q4 2018 Feb 14, 2019	SELL	$32.0 - $47.43 $1.13 Million - $1.67 Million	-35,300 Reduced 8.11%	400,000 $17 Million
Q3 2018 Nov 14, 2018	SELL	$47.1 - $62.7 $3.05 Million - $4.06 Million	-64,700 Reduced 12.94%	435,300 $20.5 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $6.19 Million - $12.4 Million	237,500 Added 90.48%	500,000 $24.7 Million
Q1 2018 May 15, 2018	SELL	$17.2 - $34.95 $5.81 Million - $11.8 Million	-337,500 Reduced 56.25%	262,500 $8.06 Million
Q4 2017 Feb 14, 2018	BUY	$12.65 - $19.0 $7.59 Million - $11.4 Million	600,000	600,000 $11 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account